🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Studying samples of tissue, blood, sputum, and urine from patien...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2001-05
Trial ID
NCT00899028
Treatments Being Tested
Monoclonal antibodies, such as pertuzumab and cetuximab, can block tumor gr...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00551421
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and cisplatin, w...
Status
Terminated
Location
Multiple Locations
Start Date
1999-08
Trial ID
NCT00530634
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2006-04
Trial ID
NCT00379509
Systemic lupus erythematosus (SLE) is a clinically common autoimmune diseas...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-10-30
Trial ID
NCT07067606
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine and temoz...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2008-06
Trial ID
NCT00714181
This project will address rare immune mediated inflammatory diseases (IMIDs...
Status
Completed
Location
St. Antonius Hospital
Start Date
2014-09
Trial ID
NCT02251964
Treatments Being Tested
RATIONALE: Diagnostic procedures, such as copper Cu 64-DOTA-trastuzumab-lab...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2011-03-16
Trial ID
NCT01093612
The purpose of the study is to evaluate if firefighter exposure to hazardou...
Status
Recruiting
Location
Levine Cancer Institute
Start Date
2026-06-23
Trial ID
NCT06870760
The purpose of the study is to investigate the clinical usefulness of serum...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2017-07-01
Trial ID
NCT03325036
Treatments Being Tested